Novavax Nuvaxovid gets full marketing authorization in EU for COVID prevention Ruchika Sharma9 July 2023 10:00 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has been granted full Marketing...
Novavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccines Ruchika Sharma1 Jan 2023 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax seeks updated Emergency Use Listing from WHO for Nuvaxovid as booster in adults Ruchika Sharma18 Sept 2022 12:30 PM ISTUS: Novavax has announced the submission of a request to the World Health Organization (WHO) to update the Emergency Use Listing (EUL) of Nuvaxovid...
SII, Novavax report full product registration in South Africa of COVID jab NVX-CoV2373 for adults aged 18 and older Ruchika Sharma14 Sept 2022 12:20 PM ISTGaithersburg: Novavax, Inc., a biotechnology company and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by...
Novavax COVID vaccine Nuvaxovid gets expanded conditional marketing nod in UK for adolescents aged 12 through 17 Ruchika Sharma27 Aug 2022 11:15 AM ISTGaithersburg: Novavax, Inc. has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted...
Novavax COVID vaccine Nuvaxovid gets provisional nod in New Zealand for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 1:45 PM ISTNuvaxovid (NVX-CoV2373) is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes...
COVID vaccine: Novavax requests WHO to expand Emergency Use Listing of Nuvaxovid for adolescents aged 12 through 17 Ruchika Sharma1 Aug 2022 3:25 PM ISTThe WHO previously granted EUL for Nuvaxovid in adults aged 18 and older in December 2021.
Novavax, SK bioscience expand agreement to manufacture COVID vaccine containing Omicron variant Ruchika Sharma24 July 2022 11:00 AM ISTGaithersburg: Novavax, Inc has signed agreements with its partner, SK bioscience, for the manufacturing and supply of a version of the Novavax...
Novavax COVID vaccine gets USFDA emergency use nod for 18 years and older Ruchika Sharma14 July 2022 12:14 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine Nuvaxovid gets European Commission conditional nod for adolescents Ruchika Sharma6 July 2022 11:36 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 12:30 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine gets emergency use nod in Taiwan for adults Ruchika Sharma24 Jun 2022 11:33 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
